nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.00958	0.0535	CcSEcCtD
Acetylcysteine—L-Cysteine—GOT1—liver cancer	0.00904	1	CrCbGaD
Acetylcysteine—Respiratory distress—Sorafenib—liver cancer	0.00886	0.0495	CcSEcCtD
Acetylcysteine—Rhinorrhoea—Sorafenib—liver cancer	0.00695	0.0388	CcSEcCtD
Acetylcysteine—Sensitisation—Epirubicin—liver cancer	0.00583	0.0325	CcSEcCtD
Acetylcysteine—Sensitisation—Doxorubicin—liver cancer	0.00539	0.0301	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Sorafenib—liver cancer	0.00365	0.0204	CcSEcCtD
Acetylcysteine—Stomatitis—Sorafenib—liver cancer	0.00307	0.0171	CcSEcCtD
Acetylcysteine—Haemoptysis—Epirubicin—liver cancer	0.00281	0.0157	CcSEcCtD
Acetylcysteine—Feeling hot—Epirubicin—liver cancer	0.00265	0.0148	CcSEcCtD
Acetylcysteine—Cardiac disorder—Sorafenib—liver cancer	0.00262	0.0147	CcSEcCtD
Acetylcysteine—Flushing—Sorafenib—liver cancer	0.00262	0.0147	CcSEcCtD
Acetylcysteine—Haemoptysis—Doxorubicin—liver cancer	0.0026	0.0145	CcSEcCtD
Acetylcysteine—Angiopathy—Sorafenib—liver cancer	0.00257	0.0143	CcSEcCtD
Acetylcysteine—Immune system disorder—Sorafenib—liver cancer	0.00255	0.0143	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Sorafenib—liver cancer	0.00255	0.0142	CcSEcCtD
Acetylcysteine—Erythema—Sorafenib—liver cancer	0.00246	0.0137	CcSEcCtD
Acetylcysteine—Feeling hot—Doxorubicin—liver cancer	0.00245	0.0137	CcSEcCtD
Acetylcysteine—Thinking abnormal—Epirubicin—liver cancer	0.00227	0.0127	CcSEcCtD
Acetylcysteine—Angioedema—Sorafenib—liver cancer	0.00225	0.0126	CcSEcCtD
Acetylcysteine—Syncope—Sorafenib—liver cancer	0.00221	0.0123	CcSEcCtD
Acetylcysteine—Loss of consciousness—Sorafenib—liver cancer	0.00216	0.0121	CcSEcCtD
Acetylcysteine—Cough—Sorafenib—liver cancer	0.00215	0.012	CcSEcCtD
Acetylcysteine—Gait disturbance—Epirubicin—liver cancer	0.00213	0.0119	CcSEcCtD
Acetylcysteine—Thinking abnormal—Doxorubicin—liver cancer	0.0021	0.0117	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00208	0.0116	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Sorafenib—liver cancer	0.00201	0.0112	CcSEcCtD
Acetylcysteine—Shock—Sorafenib—liver cancer	0.00198	0.011	CcSEcCtD
Acetylcysteine—Gait disturbance—Doxorubicin—liver cancer	0.00197	0.011	CcSEcCtD
Acetylcysteine—Skin disorder—Sorafenib—liver cancer	0.00195	0.0109	CcSEcCtD
Acetylcysteine—Mental disability—Epirubicin—liver cancer	0.00181	0.0101	CcSEcCtD
Acetylcysteine—Dyspnoea—Sorafenib—liver cancer	0.00179	0.01	CcSEcCtD
Acetylcysteine—Dyspepsia—Sorafenib—liver cancer	0.00177	0.00987	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00173	0.00968	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—liver cancer	0.00167	0.00934	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—liver cancer	0.00167	0.00933	CcSEcCtD
Acetylcysteine—Urticaria—Sorafenib—liver cancer	0.0016	0.00891	CcSEcCtD
Acetylcysteine—Body temperature increased—Sorafenib—liver cancer	0.00159	0.00887	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—liver cancer	0.00156	0.00871	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—liver cancer	0.00155	0.00864	CcSEcCtD
Acetylcysteine—Hypersensitivity—Sorafenib—liver cancer	0.00148	0.00826	CcSEcCtD
Acetylcysteine—Face oedema—Epirubicin—liver cancer	0.00146	0.00814	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00144	0.00806	CcSEcCtD
Acetylcysteine—Pruritus—Sorafenib—liver cancer	0.00142	0.00794	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—liver cancer	0.00135	0.00754	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—liver cancer	0.00135	0.00753	CcSEcCtD
Acetylcysteine—Dizziness—Sorafenib—liver cancer	0.00133	0.00742	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—liver cancer	0.00131	0.00729	CcSEcCtD
Acetylcysteine—Vomiting—Sorafenib—liver cancer	0.00128	0.00713	CcSEcCtD
Acetylcysteine—Rash—Sorafenib—liver cancer	0.00127	0.00707	CcSEcCtD
Acetylcysteine—Dermatitis—Sorafenib—liver cancer	0.00127	0.00707	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—liver cancer	0.00125	0.00698	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—liver cancer	0.00121	0.00674	CcSEcCtD
Acetylcysteine—Nausea—Sorafenib—liver cancer	0.00119	0.00666	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—liver cancer	0.00116	0.0065	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—liver cancer	0.00113	0.00634	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—liver cancer	0.00112	0.00623	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—liver cancer	0.00108	0.00601	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—liver cancer	0.00105	0.00586	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—liver cancer	0.00104	0.00579	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—liver cancer	0.00103	0.00577	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—liver cancer	0.00097	0.00541	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—liver cancer	0.00097	0.00541	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—liver cancer	0.00096	0.00536	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—liver cancer	0.000948	0.00529	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—liver cancer	0.000944	0.00527	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—liver cancer	0.000942	0.00526	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—liver cancer	0.00091	0.00508	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—liver cancer	0.000897	0.00501	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—liver cancer	0.000897	0.00501	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—liver cancer	0.000877	0.0049	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—liver cancer	0.000873	0.00488	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—liver cancer	0.000871	0.00487	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—liver cancer	0.000842	0.0047	CcSEcCtD
Acetylcysteine—Syncope—Epirubicin—liver cancer	0.000816	0.00455	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—liver cancer	0.0008	0.00446	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—liver cancer	0.000794	0.00443	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000769	0.00429	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—liver cancer	0.000755	0.00421	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—liver cancer	0.000742	0.00415	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—liver cancer	0.000742	0.00415	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—liver cancer	0.00074	0.00413	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—liver cancer	0.000734	0.0041	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—liver cancer	0.00073	0.00408	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—liver cancer	0.000725	0.00405	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—liver cancer	0.000721	0.00403	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—liver cancer	0.000718	0.00401	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000712	0.00397	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—liver cancer	0.000694	0.00387	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—liver cancer	0.000687	0.00384	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—liver cancer	0.000687	0.00384	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—liver cancer	0.000676	0.00377	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—liver cancer	0.00067	0.00374	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—liver cancer	0.000667	0.00373	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—liver cancer	0.000664	0.00371	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—liver cancer	0.000662	0.0037	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—liver cancer	0.00066	0.00369	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—liver cancer	0.000654	0.00365	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—liver cancer	0.000642	0.00358	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000641	0.00358	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—liver cancer	0.000612	0.00342	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—liver cancer	0.000611	0.00341	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—liver cancer	0.000605	0.00338	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000593	0.00331	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—liver cancer	0.00059	0.00329	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—liver cancer	0.000587	0.00328	CcSEcCtD
Acetylcysteine—Hypersensitivity—Epirubicin—liver cancer	0.000547	0.00305	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—liver cancer	0.000546	0.00305	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—liver cancer	0.000543	0.00303	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—liver cancer	0.000525	0.00293	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—liver cancer	0.000506	0.00283	CcSEcCtD
Acetylcysteine—Dizziness—Epirubicin—liver cancer	0.000491	0.00274	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—liver cancer	0.000486	0.00271	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—liver cancer	0.000472	0.00264	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—liver cancer	0.000468	0.00261	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—liver cancer	0.000468	0.00261	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—liver cancer	0.000454	0.00254	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—liver cancer	0.000441	0.00246	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—liver cancer	0.000437	0.00244	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—liver cancer	0.000433	0.00242	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—liver cancer	0.000433	0.00242	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—liver cancer	0.000408	0.00228	CcSEcCtD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—PIK3CA—liver cancer	7.36e-05	9.07e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—KRAS—liver cancer	7.33e-05	9.03e-05	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—AKT1—liver cancer	7.29e-05	8.98e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—AKT1—liver cancer	7.28e-05	8.97e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HPGDS—liver cancer	7.28e-05	8.96e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—KRAS—liver cancer	7.26e-05	8.95e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—PIK3CA—liver cancer	7.24e-05	8.91e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.23e-05	8.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PRKCE—liver cancer	7.15e-05	8.81e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KRAS—liver cancer	7.14e-05	8.8e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDH1—liver cancer	7.08e-05	8.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CD—liver cancer	7.04e-05	8.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PRKCE—liver cancer	7.02e-05	8.65e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—RAF1—liver cancer	6.93e-05	8.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HGF—liver cancer	6.93e-05	8.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ADAM17—liver cancer	6.88e-05	8.47e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD8A—liver cancer	6.85e-05	8.44e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CSF2—liver cancer	6.85e-05	8.44e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—liver cancer	6.81e-05	8.39e-05	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	6.8e-05	8.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MTOR—liver cancer	6.77e-05	8.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CB—liver cancer	6.77e-05	8.34e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CD—liver cancer	6.76e-05	8.33e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—liver cancer	6.69e-05	8.25e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ABL1—liver cancer	6.68e-05	8.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—PIK3CA—liver cancer	6.67e-05	8.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—RAF1—liver cancer	6.66e-05	8.2e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.59e-05	8.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PIK3CA—liver cancer	6.56e-05	8.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL6—liver cancer	6.52e-05	8.03e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.5e-05	8.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—MTOR—liver cancer	6.5e-05	8.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CB—liver cancer	6.5e-05	8.01e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PSMA4—liver cancer	6.48e-05	7.99e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PSMD10—liver cancer	6.48e-05	7.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PSMA4—liver cancer	6.46e-05	7.96e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PSMD10—liver cancer	6.46e-05	7.96e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—IL6—liver cancer	6.41e-05	7.89e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—liver cancer	6.39e-05	7.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CDKN1B—liver cancer	6.35e-05	7.83e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GOT2—liver cancer	6.31e-05	7.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—RAF1—liver cancer	6.29e-05	7.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HGF—liver cancer	6.28e-05	7.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—H2AFX—liver cancer	6.24e-05	7.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ADAM17—liver cancer	6.23e-05	7.68e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—liver cancer	6.23e-05	7.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD8A—liver cancer	6.21e-05	7.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CSF2—liver cancer	6.21e-05	7.65e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ALB—liver cancer	6.18e-05	7.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—liver cancer	6.17e-05	7.61e-05	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	6.15e-05	7.57e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CB—liver cancer	6.14e-05	7.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MTOR—liver cancer	6.14e-05	7.56e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—IL6—liver cancer	6.12e-05	7.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDKN1B—liver cancer	6.1e-05	7.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—liver cancer	6.07e-05	7.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—JUN—liver cancer	6.05e-05	7.45e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—RAF1—liver cancer	6.04e-05	7.44e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CTNNB1—liver cancer	6e-05	7.39e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—IL6—liver cancer	5.96e-05	7.35e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP2E1—liver cancer	5.93e-05	7.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—liver cancer	5.91e-05	7.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL6—liver cancer	5.91e-05	7.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CB—liver cancer	5.9e-05	7.26e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—MTOR—liver cancer	5.9e-05	7.26e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CDKN1A—liver cancer	5.86e-05	7.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2L1—liver cancer	5.86e-05	7.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PSMA4—liver cancer	5.86e-05	7.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PSMD10—liver cancer	5.86e-05	7.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IL6—liver cancer	5.81e-05	7.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CDKN1B—liver cancer	5.76e-05	7.1e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.74e-05	7.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MAPK8—liver cancer	5.72e-05	7.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTHFR—liver cancer	5.66e-05	6.97e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—liver cancer	5.64e-05	6.95e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TERT—liver cancer	5.64e-05	6.95e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDKN1A—liver cancer	5.63e-05	6.94e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	5.59e-05	6.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK14—liver cancer	5.55e-05	6.84e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYCS—liver cancer	5.55e-05	6.84e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDKN1B—liver cancer	5.53e-05	6.81e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—liver cancer	5.5e-05	6.78e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—JUN—liver cancer	5.48e-05	6.76e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GOT1—liver cancer	5.45e-05	6.71e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GGT1—liver cancer	5.45e-05	6.71e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CTNNB1—liver cancer	5.44e-05	6.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—liver cancer	5.36e-05	6.6e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CDKN1A—liver cancer	5.32e-05	6.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2L1—liver cancer	5.32e-05	6.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MAPK8—liver cancer	5.19e-05	6.39e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PIK3CA—liver cancer	5.13e-05	6.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDKN1A—liver cancer	5.11e-05	6.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK14—liver cancer	5.03e-05	6.2e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PRKCE—liver cancer	5.01e-05	6.17e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTP1—liver cancer	4.89e-05	6.02e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HMOX1—liver cancer	4.82e-05	5.94e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APC—liver cancer	4.75e-05	5.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF2—liver cancer	4.74e-05	5.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDH1—liver cancer	4.74e-05	5.83e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PRKCE—liver cancer	4.54e-05	5.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CD—liver cancer	4.52e-05	5.57e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTM1—liver cancer	4.49e-05	5.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—liver cancer	4.49e-05	5.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—BRAF—liver cancer	4.47e-05	5.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CSF2—liver cancer	4.43e-05	5.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—H2AFX—liver cancer	4.37e-05	5.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—liver cancer	4.31e-05	5.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF2—liver cancer	4.3e-05	5.3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDH1—liver cancer	4.29e-05	5.29e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP1A1—liver cancer	4.26e-05	5.25e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—liver cancer	4.19e-05	5.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CD—liver cancer	4.18e-05	5.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SERPINE1—liver cancer	4.13e-05	5.09e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CA—liver cancer	4.13e-05	5.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CD—liver cancer	4.1e-05	5.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—liver cancer	4.07e-05	5.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—RAF1—liver cancer	4.04e-05	4.97e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CSF2—liver cancer	4.02e-05	4.95e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MTHFR—liver cancer	3.97e-05	4.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CA—liver cancer	3.96e-05	4.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—H2AFX—liver cancer	3.96e-05	4.88e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TERT—liver cancer	3.95e-05	4.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CB—liver cancer	3.94e-05	4.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MTOR—liver cancer	3.94e-05	4.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—liver cancer	3.91e-05	4.82e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARA—liver cancer	3.9e-05	4.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—liver cancer	3.82e-05	4.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CA—liver cancer	3.74e-05	4.61e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—RAF1—liver cancer	3.73e-05	4.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1B—liver cancer	3.7e-05	4.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—liver cancer	3.67e-05	4.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—RAF1—liver cancer	3.66e-05	4.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—liver cancer	3.65e-05	4.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CB—liver cancer	3.64e-05	4.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTOR—liver cancer	3.64e-05	4.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2—liver cancer	3.62e-05	4.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KDR—liver cancer	3.61e-05	4.45e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CA—liver cancer	3.59e-05	4.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK14—liver cancer	3.59e-05	4.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TERT—liver cancer	3.58e-05	4.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MTOR—liver cancer	3.58e-05	4.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CB—liver cancer	3.58e-05	4.4e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—JUN—liver cancer	3.52e-05	4.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ESR1—liver cancer	3.52e-05	4.34e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.5e-05	4.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTNNB1—liver cancer	3.5e-05	4.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—F2—liver cancer	3.48e-05	4.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—liver cancer	3.46e-05	4.26e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1B—liver cancer	3.42e-05	4.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1A—liver cancer	3.42e-05	4.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—liver cancer	3.37e-05	4.15e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1B—liver cancer	3.36e-05	4.13e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CG—liver cancer	3.34e-05	4.11e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK8—liver cancer	3.33e-05	4.11e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CG—liver cancer	3.33e-05	4.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APC—liver cancer	3.33e-05	4.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—liver cancer	3.32e-05	4.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—liver cancer	3.31e-05	4.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2—liver cancer	3.28e-05	4.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KDR—liver cancer	3.28e-05	4.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK14—liver cancer	3.25e-05	4.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—liver cancer	3.24e-05	3.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CTNNB1—liver cancer	3.23e-05	3.98e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARG—liver cancer	3.22e-05	3.97e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—JUN—liver cancer	3.19e-05	3.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ESR1—liver cancer	3.19e-05	3.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTNNB1—liver cancer	3.17e-05	3.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1A—liver cancer	3.15e-05	3.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—F2—liver cancer	3.15e-05	3.88e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BRAF—liver cancer	3.13e-05	3.85e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1A—liver cancer	3.1e-05	3.81e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—liver cancer	3.06e-05	3.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—STAT3—liver cancer	3.05e-05	3.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK8—liver cancer	3.02e-05	3.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APC—liver cancer	3.02e-05	3.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CG—liver cancer	3.02e-05	3.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—liver cancer	2.94e-05	3.62e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CD—liver cancer	2.93e-05	3.61e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CD—liver cancer	2.92e-05	3.6e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ALB—liver cancer	2.9e-05	3.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SERPINE1—liver cancer	2.89e-05	3.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BRAF—liver cancer	2.84e-05	3.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—STAT3—liver cancer	2.81e-05	3.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—STAT3—liver cancer	2.76e-05	3.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CD—liver cancer	2.65e-05	3.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SERPINE1—liver cancer	2.62e-05	3.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—liver cancer	2.62e-05	3.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—liver cancer	2.61e-05	3.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RAF1—liver cancer	2.61e-05	3.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFB1—liver cancer	2.61e-05	3.21e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CB—liver cancer	2.56e-05	3.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MTOR—liver cancer	2.55e-05	3.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CB—liver cancer	2.55e-05	3.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—liver cancer	2.42e-05	2.98e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CA—liver cancer	2.4e-05	2.96e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1B—liver cancer	2.39e-05	2.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—liver cancer	2.37e-05	2.92e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RAF1—liver cancer	2.37e-05	2.92e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—liver cancer	2.34e-05	2.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2—liver cancer	2.34e-05	2.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CB—liver cancer	2.31e-05	2.85e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MTOR—liver cancer	2.31e-05	2.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—liver cancer	2.28e-05	2.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JUN—liver cancer	2.28e-05	2.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CTNNB1—liver cancer	2.26e-05	2.78e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—liver cancer	2.22e-05	2.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CA—liver cancer	2.22e-05	2.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—liver cancer	2.22e-05	2.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1A—liver cancer	2.21e-05	2.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CA—liver cancer	2.18e-05	2.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1B—liver cancer	2.17e-05	2.67e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK8—liver cancer	2.16e-05	2.65e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—liver cancer	2.13e-05	2.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—liver cancer	2.13e-05	2.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2—liver cancer	2.12e-05	2.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—liver cancer	2.07e-05	2.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JUN—liver cancer	2.07e-05	2.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—liver cancer	2.05e-05	2.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CTNNB1—liver cancer	2.05e-05	2.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—liver cancer	2.02e-05	2.48e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—liver cancer	2.01e-05	2.48e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1A—liver cancer	2e-05	2.47e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—liver cancer	1.99e-05	2.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT3—liver cancer	1.97e-05	2.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—liver cancer	1.97e-05	2.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—liver cancer	1.96e-05	2.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK8—liver cancer	1.95e-05	2.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—liver cancer	1.93e-05	2.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—liver cancer	1.83e-05	2.26e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFB1—liver cancer	1.83e-05	2.25e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—liver cancer	1.81e-05	2.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—liver cancer	1.8e-05	2.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT3—liver cancer	1.79e-05	2.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—liver cancer	1.78e-05	2.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—liver cancer	1.69e-05	2.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—liver cancer	1.66e-05	2.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFB1—liver cancer	1.66e-05	2.04e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CA—liver cancer	1.56e-05	1.92e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CA—liver cancer	1.55e-05	1.91e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—liver cancer	1.53e-05	1.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—liver cancer	1.5e-05	1.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—liver cancer	1.44e-05	1.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CA—liver cancer	1.41e-05	1.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—liver cancer	1.38e-05	1.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—liver cancer	1.36e-05	1.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—liver cancer	1.3e-05	1.61e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—liver cancer	1.27e-05	1.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—liver cancer	1.27e-05	1.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—liver cancer	1.25e-05	1.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—liver cancer	1.15e-05	1.42e-05	CbGpPWpGaD
